FIUME, LUIGI

FIUME, LUIGI  

DIP. DI PATOLOGIA SPERIMENTALE  

Mostra records
Risultati 1 - 20 di 30 (tempo di esecuzione: 0.068 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentation grade. Di Stefano G.; Fiume L.; Baglioni M.; Bolondi L.; Busi C.; Chieco P.; Kratz F.; Manaresi F.; Pari...ali M. 2006-01-01 LIVER INTERNATIONAL - 1.01 Articolo in rivista -
A novel method for coupling doxorubicin to lactosaminated human albumin by an acid sensitive hydrazone bond: synthesis, characterization and preliminary biological properties of the conjugate. DI STEFANO G.; LANZA M.; KRATZ F.; MERINA L.; FIUME L. 2004-01-01 EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES - 1.01 Articolo in rivista -
Albumin-drug conjugates in the treatment of hepatic disorders. Fiume L;Manerba M;Di Stefano G 2014-01-01 EXPERT OPINION ON DRUG DELIVERY - 1.01 Articolo in rivista -
Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moieties. Baglioni M.; Fiume L.; Bolondi L.; Farina C.; Kratz F.; Di Stefano G. 2008-01-01 DIGESTIVE AND LIVER DISEASE - 1.01 Articolo in rivista -
Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy. Boga C.; Fiume L.; Baglioni M.; Bertucci C.; Farina C.; Kratz F.; Manerba M.; Naldi M.; Di Stefan...o G. 2009-01-01 EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES - 1.01 Articolo in rivista -
Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin Di Stefano G; Fiume L; Baglioni M; Busi C; Chieco P; Kratz F; Mattioli A. 2007-01-01 EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES - 1.01 Articolo in rivista -
Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine. FIUME L.; BOLONDI L.; BUSI C.; CHIECO P.; KRATZ F.; LANZA M.; MATTIOLI A.; DI STEFANO G. 2005-01-01 JOURNAL OF HEPATOLOGY - 1.01 Articolo in rivista -
Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats. Di Stefano G.; Fiume L.; Baglioni M.; Busi C.; Bolondi L.; Farina C.; Mori F.; Chieco P.; Pariali... M.; Kratz F.; Molin L.; Salmaso S.; Caliceti P. 2008-01-01 EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES - 1.01 Articolo in rivista -
Doxorubicin coupled to lactosaminated albumin: effects on rats with liver fibrosis and cirrhosis. Di Stefano G; Fiume L; Domenicali M; Busi C; Chieco P; Kratz F; Lanza M; Mattioli A; Pariali M; B...ernardi M. 2006-01-01 DIGESTIVE AND LIVER DISEASE - 1.01 Articolo in rivista -
Doxorubicin coupled to lactosaminated albumin: enhanced drug levels in rat hepatocarcinomas. Di Stefano G.; Busi C.; Chieco P.; Pariali M.; Fiume L. 2006-01-01 DIGESTIVE AND LIVER DISEASE - 1.01 Articolo in rivista -
Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug. Fiume L.; Baglioni M.; Bolondi L.; Farina C.; Di Stefano G. 2008-01-01 DRUG DISCOVERY TODAY - 1.01 Articolo in rivista -
Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells. Fiume L.; Manerba M.; Vettraino M.; Di Stefano G. 2011-01-01 EUROPEAN JOURNAL OF PHARMACOLOGY - 1.01 Articolo in rivista -
Efficacy of doxorubicin coupled to lactosaminated albumin on rat hepatocellular carcinomas evaluated by ultrasound imaging. Di Stefano G.; Fiume L.; Baglioni M.; Bolondi L.; Chieco P.; Kratz F.; Pariali M.; Rubini G. 2008-01-01 DIGESTIVE AND LIVER DISEASE - 1.01 Articolo in rivista -
Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors. DI STEFANO G.; FIUME L.; BOLONDI L.; LANZA M.; PARIALI M.; CHIECO P. 2005-01-01 LIVER INTERNATIONAL - 1.01 Articolo in rivista -
Galloflavin (CAS 568-80-9), a novel inhibitor of lactate dehydrogenase. Manerba M.; Vettraino M.; Fiume L.; Di Stefano G.; Sartini A.; Giacomini E.; Buonfiglio R.; Rober...ti M.; Recanatini M. 2012-01-01 CHEMMEDCHEM - 1.01 Articolo in rivista -
Galloflavin prevents the binding of lactate dehydrogenase A to single stranded DNA and inhibits RNA synthesis in cultured cells. Fiume L.; Vettraino M.; Carnicelli D.; Arfilli V.; Di Stefano G.; Brigotti M. 2013-01-01 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS - 1.01 Articolo in rivista -
Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways. Farabegoli F.; Vettraino M.; Manerba M.; Fiume L.; Roberti M.; Di Stefano G. 2012-01-01 EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES - 1.01 Articolo in rivista -
Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines. Fiume L; Manerba M; Vettraino M; Di Stefano G 2010-01-01 PHARMACOLOGY - 1.01 Articolo in rivista -
The inhibition of lactate dehydrogenase A hinders the transcription of histone 2B gene independently from the block of aerobic glycolysis Brighenti, Elisa; Carnicelli, Domenica; Brigotti, Maurizio; Fiume, Luigi 2017-01-01 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS - 1.01 Articolo in rivista -
Inhibition of lactate dehydrogenase activity as an approach to cancer therapy Luigi FIUME; Marcella MANERBA; Marina VETTRAINO; Giuseppina DI STEFANO 2014-01-01 FUTURE MEDICINAL CHEMISTRY - 1.01 Articolo in rivista -